Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study of weekly carboplatin and concurrent radiotherapy in older adults with locally advanced non-small cell lung cancer (LOGIK1902).
Harada T, Sasaki T, Ishii H, Takemoto S, Hisamatsu Y, Saito H, Yoneshima Y, Komiya K, Kashiwabara K, Naoki K, Ogawa T, Takeoka H, Saruwatari K, Ito K, Tsuchiya-Kawano Y, Mizuno K, Shimose T, Shioyama Y, Okamoto I. Harada T, et al. Among authors: takeoka h. Thorac Cancer. 2024 Oct;15(29):2128-2135. doi: 10.1111/1759-7714.15444. Epub 2024 Sep 8. Thorac Cancer. 2024. PMID: 39245951 Free PMC article. Clinical Trial.
A multicenter phase II trial of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanced non-squamous non-small cell lung cancer.
Yamada K, Ichiki M, Takahashi K, Hisamatsu Y, Takeoka H, Azuma K, Shukuya T, Nishikawa K, Tokito T, Ishii H, Hoshino T. Yamada K, et al. Among authors: takeoka h. Cancer Chemother Pharmacol. 2016 Sep;78(3):501-7. doi: 10.1007/s00280-016-3101-z. Epub 2016 Jul 11. Cancer Chemother Pharmacol. 2016. PMID: 27402398 Clinical Trial.
Aplastic anemia in a lung adenocarcinoma patient receiving pemetrexed.
Matama G, Tokito T, Takeoka H, Hiraoka Y, Matsuo N, Nakamura M, Ishii H, Kinoshita T, Azuma K, Yamada K, Hoshino T. Matama G, et al. Among authors: takeoka h. Invest New Drugs. 2017 Oct;35(5):662-664. doi: 10.1007/s10637-017-0462-z. Epub 2017 Mar 30. Invest New Drugs. 2017. PMID: 28361276
Impact of the pretreatment prognostic nutritional index on the survival after first-line immunotherapy in non-small-cell lung cancer patients.
Oku Y, Toyokawa G, Wakasu S, Kinoshita F, Takamori S, Watanabe K, Haratake N, Nagano T, Kosai K, Takada K, Fujimoto A, Higashijima K, Shiraishi Y, Tanaka K, Takeoka H, Okamoto M, Yamashita T, Shimokawa M, Shoji F, Yamazaki K, Okamoto T, Seto T, Ueda H, Takeo S, Nakashima N, Okamoto I, Takenaka T, Yoshizumi T. Oku Y, et al. Among authors: takeoka h. Cancer Med. 2023 Jul;12(13):14327-14336. doi: 10.1002/cam4.6110. Epub 2023 May 21. Cancer Med. 2023. PMID: 37211905 Free PMC article.
Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours.
Seto T, Esaki T, Hirai F, Arita S, Nosaki K, Makiyama A, Kometani T, Fujimoto C, Hamatake M, Takeoka H, Agbo F, Shi X. Seto T, et al. Among authors: takeoka h. Cancer Chemother Pharmacol. 2013 Sep;72(3):619-27. doi: 10.1007/s00280-013-2234-6. Epub 2013 Jul 28. Cancer Chemother Pharmacol. 2013. PMID: 23892959 Clinical Trial.
109 results